JW
James N. Woody
Chief Executive OfficerDirector

James N. Woody insider trades: 180 Life Sciences (ATNF) stock purchases

Chief Executive Officer, 180 Life Sciences Last trade Dec 15, 2023 9 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2013
3
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where James reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 15, 2023ATNF↑ Buy$5K
May 18, 2023ATNF↑ Buy$41K
Dec 9, 2021ATNF↑ Buy$53K
Nov 9, 2020ATNF↑ Buy$3K
Dec 17, 2013TLOG↑ Buy$1.8M
Jul 23, 2013OMED↑ Buy$735K
Jul 23, 2013OMED↑ Buy$575K
Jul 23, 2013OMED↑ Buy$135K
Jul 23, 2013OMED↑ Buy$37K
Jul 23, 2013OMED↑ Buy$18K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About James N. Woody's insider trades

James N. Woody is Chief Executive Officer at 180 Life Sciences (ATNF). Since Jul 23, 2013, James has reported 10 open-market purchases worth $3.4M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (3 filings), conversions (2 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ATNF insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.